KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Cash from Operations (2018 - 2025)

ClearPoint Neuro's Cash from Operations history spans 13 years, with the latest figure at 3121000.0 for Q3 2025.

  • For Q3 2025, Cash from Operations fell 160.3% year-over-year to 3121000.0; the TTM value through Sep 2025 reached 13138000.0, down 48.02%, while the annual FY2024 figure was 9000000.0, 34.4% up from the prior year.
  • Cash from Operations for Q3 2025 was 3121000.0 at ClearPoint Neuro, down from 2524000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1169000.0 in Q4 2023 and bottomed at 6200000.0 in Q1 2025.
  • The 5-year median for Cash from Operations is 3296000.0 (2021), against an average of 3338368.42.
  • The largest annual shift saw Cash from Operations skyrocketed 61.86% in 2023 before it tumbled 160.3% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 3552000.0 in 2021, then rose by 13.71% to 3065000.0 in 2022, then surged by 61.86% to 1169000.0 in 2023, then fell by 10.61% to 1293000.0 in 2024, then plummeted by 141.38% to 3121000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Cash from Operations are 3121000.0 (Q3 2025), 2524000.0 (Q2 2025), and 6200000.0 (Q1 2025).